Journal: Molecular Therapy
Article Title: Multiple-omics analysis reveals a dedifferentiation-immune loop in intrahepatic cholangiocarcinoma
doi: 10.1016/j.ymthe.2025.02.019
Figure Lengend Snippet: Malignant cells induce immunosuppressive macrophages (A) A list of immune checkpoints expressed by TAM was set as GOI. Violin plot showed the expressions of seven GOI immune checkpoints in macrophages based on feature genes from four subcluster macrophages. (B) The interaction potential between the ligands on each malignant cell cluster and the GOIs of macrophages were examined. Using a color key ranging from gray to green, the interaction potential was visualized, with green indicating high interaction potential and gray indicating low interaction potential. (C) To evaluate the prognostic significance of immune checkpoint expression in patients with ICC, a Kaplan-Meier survival curve was constructed based on proteomic data from our in-house cohort of 110 patients with ICC. The p values obtained from two-sided log rank tests were used to assess the statistical significance of the survival differences. (D) IHC staining was performed to examine the expression of two immune checkpoints, LILRB1 and LILRB2, in peritumoral tissues (adjacent normal tissues) and ICC tissues. The staining results were visualized using a scale bar, and a magnification of 40 μm was used. (E) Kaplan-Meier survival curve of LILRB1 (left, p = 0.03, hazard ratio, 0.35; 95% confidence interval [CI]:, 0.14–0.91) and LILRB2 (right, p = 0.078, hazard ratio, 0.39; 95% CI, 0.14–1.11) expression in patients with ICC (from our own collection). p values were obtained from two-sided log rank tests. (F) t-SNE plots were generated to visualize the expression levels of LILRB1 and LILRB2 in the tumor TME of ICC. The color key ranged from gray to blue, with blue indicating high expression levels and gray indicating low expression levels. (G) Flow cytometry analysis was performed to confirm the expression of LILRB1 and LILRB2 by TAM in the TME of ICC. The results showed that TAM indeed expressed these immune checkpoints. (H) IF staining was used to further validate the expression of LILRB1 and LILRB2 by TAM in patients' samples. CD68 was used to label macrophages, and a scale bar representing 10 μm was used to visualize the staining results. (I) Western blot assay was conducted to compare the expression of active YAP1, a downstream signaling molecule, in a normal bile duct epithelial cell line (HIBEC) and several ICC cell lines. For the statistical analysis of active YAP1/actin level, ∗∗∗∗ p < 0.0001. (J and K) IF showed the LILRB1/2 staining. In brief, 80 nM PMA was used to induce THP-1 cell to M0 macrophages and incubated for 48 h then directly co-cultured with normal bile duct epithelial cell line HIBECs and ICC cell line CCLP1 and HCCC9810 for another 24 h. Scale bar, 10 μm ∗∗∗ p < 0.001. All experiments were independently repeated more than three times to ensure reproducibility.
Article Snippet: Following permeabilization, cells were blocked with 2% BSA for 1 h and then labeled with primary antibodies against CD68 (sc-20060, Santa Cruz), LILRB1 (ab170909, Abcam), or LILRB2 (abs139124, Absin) for 1 h. Subsequently, the cells were incubated with the secondary antibodies for 1 h in the dark.
Techniques: Expressing, Construct, Immunohistochemistry, Staining, Generated, Flow Cytometry, Western Blot, Incubation, Cell Culture